Some Investors May Be Willing To Look Past LifeTech Scientific's (HKG:1302) Soft Earnings
Some Investors May Be Willing To Look Past LifeTech Scientific's (HKG:1302) Soft Earnings
The market for LifeTech Scientific Corporation's (HKG:1302) shares didn't move much after it posted weak earnings recently. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.
最近,生命科技科学公司(HKG:1302)的股票市场并未因弱势盈利而有太大波动。我们认为,较软的主要数字可能被一些积极的潜在因素所抵消。
How Do Unusual Items Influence Profit?
非常规项目如何影响利润?
To properly understand LifeTech Scientific's profit results, we need to consider the CN¥139m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. LifeTech Scientific took a rather significant hit from unusual items in the year to June 2024. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.
要正确理解生命科技科学公司的盈利结果,我们需要考虑到飞凡项所产生的人民币13900万的开支。看到飞凡项影响公司盈利并不令人愉快,但好的是,情况可能会比想象中更快好转。当我们分析世界范围内绝大多数上市公司时,发现重要的飞凡项通常不会重复发生。而且,归根结底,这正是会计术语的含义。生命科技科学公司在2024年6月的财年中受到了飞凡项的相当大损失。因此,我们可以推断,飞凡项使其法定利润明显较之原本更为疲软。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。
Our Take On LifeTech Scientific's Profit Performance
我们对生命科技科学公司的盈利表现看法
As we mentioned previously, the LifeTech Scientific's profit was hampered by unusual items in the last year. Based on this observation, we consider it possible that LifeTech Scientific's statutory profit actually understates its earnings potential! On the other hand, its EPS actually shrunk in the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into LifeTech Scientific, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 3 warning signs for LifeTech Scientific you should know about.
正如我们之前提到的,飞凡在过去的一年中的利润受到了一些异常因素的影响。根据这一观察,我们认为飞凡的法定利润实际上低估了其盈利潜力!另一方面,飞凡的每股收益在过去的十二个月中实际上有所下降。总而言之,如果您想正确地了解这家公司,就必须考虑更多因素。如果您想深入了解飞凡科技公司,您还需要了解其目前面临的风险。每个公司都有风险,我们已经发现了3个警示信号,您应该了解一下。
This note has only looked at a single factor that sheds light on the nature of LifeTech Scientific's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
这篇笔记只关注了揭示飞凡科技公司盈利性质的一个因素。但是还有很多其他方法可以了解一家公司的情况。例如,很多人认为股本回报率高是有利的商业经济指标,而其他人则喜欢“追踪资金”并寻找内部人员正在购买的股票。因此,您可能希望查看这个免费收集股本回报率高的公司列表,或者这个高内部持股的股票列表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。